Developing new biopharmaceutical products for infectious diseases
Preclinical Services for Biopharmaceutical Product Development
['FUNDING_OTHER'] · LATHAM BIOPHARM GROUP, INC. · NIH-10934794
This study is working on improving new treatments, like antibodies and special proteins, to help fight infections, so patients can eventually benefit from better therapies.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LATHAM BIOPHARM GROUP, INC. (nih funded) |
| Locations | 1 site (CAMBRIDGE, UNITED STATES) |
| Trial ID | NIH-10934794 on ClinicalTrials.gov |
What this research studies
This research focuses on providing essential services for the preclinical development of biopharmaceutical products, including monoclonal antibodies, recombinant proteins, and nucleic acid-based vectors like small interfering RNA. The program aims to facilitate the planning, evaluation, and characterization of these products, ensuring they are effectively developed for use against infectious diseases. Patients may benefit from advancements in treatments that arise from this preclinical work, as it supports the translation of innovative therapies into clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals affected by infectious diseases who may be treated with novel biopharmaceutical products.
Not a fit: Patients with non-infectious diseases or those not responding to biopharmaceutical treatments may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infectious diseases.
How similar studies have performed: Other research in biopharmaceutical development has shown success in translating preclinical findings into effective treatments, indicating a promising potential for this approach.
Where this research is happening
CAMBRIDGE, UNITED STATES
- LATHAM BIOPHARM GROUP, INC. — CAMBRIDGE, UNITED STATES (ACTIVE)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Infectious Diseases Research, Infectious Diseases / Laboratory